November 10, 2021
A federal judge in Washington, D.C., has ruled that the federal government can't go after Novartis and United Therapeutics over their marketing policies limiting the number of drugs sold as part of a federal drug discount program for low-income patients, a decision that departs from recent rulings against other pharmaceutical companies.